Logo image of GBLB.BR

GROUPE BRUXELLES LAMBERT NV (GBLB.BR) Stock Fundamental Analysis

EBR:GBLB - Euronext Brussels - BE0003797140 - Common Stock - Currency: EUR

73.85  -0.1 (-0.14%)

Fundamental Rating

3

Overall GBLB gets a fundamental rating of 3 out of 10. We evaluated GBLB against 51 industry peers in the Financial Services industry. The financial health of GBLB is average, but there are quite some concerns on its profitability. GBLB does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year GBLB was profitable.
In the past year GBLB had a positive cash flow from operations.
Of the past 5 years GBLB 4 years were profitable.
GBLB had a positive operating cash flow in each of the past 5 years.
GBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFGBLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

1.2 Ratios

GBLB's Return On Assets of 0.37% is on the low side compared to the rest of the industry. GBLB is outperformed by 70.59% of its industry peers.
GBLB has a Return On Equity of 0.73%. This is in the lower half of the industry: GBLB underperforms 68.63% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.80%, GBLB is doing worse than 62.75% of the companies in the same industry.
GBLB had an Average Return On Invested Capital over the past 3 years of 0.81%. This is significantly below the industry average of 11.50%.
The last Return On Invested Capital (1.80%) for GBLB is above the 3 year average (0.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.37%
ROE 0.73%
ROIC 1.8%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
GBLB.BR Yearly ROA, ROE, ROICGBLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 1.03%, GBLB is doing worse than 70.59% of the companies in the same industry.
GBLB's Profit Margin has declined in the last couple of years.
The Operating Margin of GBLB (7.50%) is worse than 64.71% of its industry peers.
GBLB's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 66.90%, GBLB is in the better half of the industry, outperforming 62.75% of the companies in the same industry.
GBLB's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.5%
PM (TTM) 1.03%
GM 66.9%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
GBLB.BR Yearly Profit, Operating, Gross MarginsGBLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

4

2. Health

2.1 Basic Checks

GBLB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
GBLB has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, GBLB has less shares outstanding
Compared to 1 year ago, GBLB has a worse debt to assets ratio.
GBLB.BR Yearly Shares OutstandingGBLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
GBLB.BR Yearly Total Debt VS Total AssetsGBLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

Based on the Altman-Z score of 1.45, we must say that GBLB is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.45, GBLB perfoms like the industry average, outperforming 49.02% of the companies in the same industry.
The Debt to FCF ratio of GBLB is 10.80, which is on the high side as it means it would take GBLB, 10.80 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 10.80, GBLB perfoms like the industry average, outperforming 43.14% of the companies in the same industry.
A Debt/Equity ratio of 0.48 indicates that GBLB is not too dependend on debt financing.
With a Debt to Equity ratio value of 0.48, GBLB perfoms like the industry average, outperforming 50.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 10.8
Altman-Z 1.45
ROIC/WACC0.3
WACC5.99%
GBLB.BR Yearly LT Debt VS Equity VS FCFGBLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

GBLB has a Current Ratio of 1.95. This is a normal value and indicates that GBLB is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.95, GBLB is in the better half of the industry, outperforming 76.47% of the companies in the same industry.
GBLB has a Quick Ratio of 1.58. This is a normal value and indicates that GBLB is financially healthy and should not expect problems in meeting its short term obligations.
GBLB has a Quick ratio of 1.58. This is in the better half of the industry: GBLB outperforms 76.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.58
GBLB.BR Yearly Current Assets VS Current LiabilitesGBLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

The earnings per share for GBLB have decreased strongly by -96.80% in the last year.
Measured over the past years, GBLB shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -26.51% on average per year.
The Revenue has decreased by -1.35% in the past year.
GBLB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.51% yearly.
EPS 1Y (TTM)-96.8%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-112.25%
Revenue 1Y (TTM)-1.35%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%-3.51%

3.2 Future

Based on estimates for the next years, GBLB will show a very negative growth in Earnings Per Share. The EPS will decrease by -14.59% on average per year.
Based on estimates for the next years, GBLB will show a small growth in Revenue. The Revenue will grow by 2.33% on average per year.
EPS Next Y-21.19%
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%
EPS Next 5YN/A
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
GBLB.BR Yearly Revenue VS EstimatesGBLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
GBLB.BR Yearly EPS VS EstimatesGBLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 108.60, the valuation of GBLB can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of GBLB indicates a slightly more expensive valuation: GBLB is more expensive than 74.51% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, GBLB is valued quite expensively.
With a Price/Forward Earnings ratio of 21.05, GBLB is valued on the expensive side.
GBLB's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, GBLB is valued at the same level.
Industry RankSector Rank
PE 108.6
Fwd PE 21.05
GBLB.BR Price Earnings VS Forward Price EarningsGBLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

64.71% of the companies in the same industry are more expensive than GBLB, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, GBLB is valued a bit cheaper than the industry average as 68.63% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.17
EV/EBITDA 9.38
GBLB.BR Per share dataGBLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

A cheap valuation may be justified as GBLB's earnings are expected to decrease with -14.59% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.80%, GBLB is a good candidate for dividend investing.
GBLB's Dividend Yield is rather good when compared to the industry average which is at 3.51. GBLB pays more dividend than 82.35% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.37, GBLB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.8%

5.2 History

The dividend of GBLB decreases each year by -2.00%.
Dividend Growth(5Y)-2%
Div Incr Years1
Div Non Decr Years4
GBLB.BR Yearly Dividends per shareGBLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

GBLB pays out 346.34% of its income as dividend. This is not a sustainable payout ratio.
GBLB's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP346.34%
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%
GBLB.BR Yearly Income VS Free CF VS DividendGBLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B
GBLB.BR Dividend Payout.GBLB.BR Dividend Payout, showing the Payout Ratio.GBLB.BR Dividend Payout.PayoutRetained Earnings

GROUPE BRUXELLES LAMBERT NV

EBR:GBLB (7/11/2025, 7:00:00 PM)

73.85

-0.1 (-0.14%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-02 2025-05-02
Earnings (Next)07-31 2025-07-31
Inst Owners26.43%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap9.84B
Analysts83.08
Price Target87.98 (19.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.8%
Yearly Dividend2.78
Dividend Growth(5Y)-2%
DP346.34%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.47%
PT rev (3m)-3.04%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.99%
Valuation
Industry RankSector Rank
PE 108.6
Fwd PE 21.05
P/S 0.99
P/FCF 13.17
P/OCF 7.4
P/B 0.7
P/tB 1.37
EV/EBITDA 9.38
EPS(TTM)0.68
EY0.92%
EPS(NY)3.51
Fwd EY4.75%
FCF(TTM)5.61
FCFY7.59%
OCF(TTM)9.98
OCFY13.51%
SpS74.79
BVpS106.03
TBVpS53.85
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.37%
ROE 0.73%
ROCE 3.05%
ROIC 1.8%
ROICexc 2.1%
ROICexgc 3.14%
OM 7.5%
PM (TTM) 1.03%
GM 66.9%
FCFM 7.5%
ROA(3y)1.59%
ROA(5y)1.37%
ROE(3y)2.81%
ROE(5y)2.38%
ROIC(3y)0.81%
ROIC(5y)1.13%
ROICexc(3y)0.92%
ROICexc(5y)1.25%
ROICexgc(3y)1.32%
ROICexgc(5y)1.66%
ROCE(3y)1.37%
ROCE(5y)1.91%
ROICexcg growth 3Y-6.63%
ROICexcg growth 5Y-8.4%
ROICexc growth 3Y-11.16%
ROICexc growth 5Y-11.6%
OM growth 3Y-18.48%
OM growth 5Y-18.66%
PM growth 3Y-21.26%
PM growth 5Y-30.86%
GM growth 3Y-5.44%
GM growth 5Y-0.69%
F-Score8
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.48
Debt/FCF 10.8
Debt/EBITDA 5.21
Cap/Depr 104.41%
Cap/Sales 5.84%
Interest Coverage 2.06
Cash Conversion 101.89%
Profit Quality 728.78%
Current Ratio 1.95
Quick Ratio 1.58
Altman-Z 1.45
F-Score8
WACC5.99%
ROIC/WACC0.3
Cap/Depr(3y)97.68%
Cap/Depr(5y)87.97%
Cap/Sales(3y)10%
Cap/Sales(5y)8.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.8%
EPS 3Y-18.6%
EPS 5Y-26.51%
EPS Q2Q%-112.25%
EPS Next Y-21.19%
EPS Next 2Y-8.21%
EPS Next 3Y-14.59%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.35%
Revenue growth 3Y-0.95%
Revenue growth 5Y3.51%
Sales Q2Q%-3.51%
Revenue Next Year0.99%
Revenue Next 2Y1.99%
Revenue Next 3Y2.33%
Revenue Next 5YN/A
EBIT growth 1Y-30.37%
EBIT growth 3Y-19.25%
EBIT growth 5Y-15.81%
EBIT Next Year9.24%
EBIT Next 3Y5.06%
EBIT Next 5YN/A
FCF growth 1Y60.4%
FCF growth 3Y8.34%
FCF growth 5Y2.47%
OCF growth 1Y18.45%
OCF growth 3Y8.48%
OCF growth 5Y4.55%